💡 本文重點導覽
- The established mechanisms
- 2024 concerns: lean mass loss and cardiovascular signals
- Who intermittent fasting may and may not be appropriate for
📋 本文重點摘要
Intermittent fasting has strong mechanistic support for improving insulin sensitivity and metabolic markers, but 2024–2025 research has raised important questions about muscle loss risk and cardiovascular safety. This article reviews the current evidence.
Intermittent fasting has strong mechanistic support for improving insulin sensitivity and metabolic markers, but 2024–20…
Intermittent fasting (IF) — particularly time-restricted eating (TRE/16:8) and alternate-day fasting — has been one of the most researched dietary strategies of the last decade. The basic premise is sound: restricting the eating window allows extended periods of low insulin that enable fat mobilization. But 2024–2025 research has added important nuance that complicates straightforward recommendations.
The established mechanisms
During fasting, insulin falls, glucagon rises, and the body shifts from glucose oxidation to fat oxidation — specifically ketone body production from hepatic fatty acid oxidation. Extended fasting also activates autophagy (cellular “self-cleaning”), increases growth hormone pulsatility, and reduces chronic low-grade inflammation. These are real mechanisms supported by extensive basic science. Clinical trials consistently show that IF improves insulin sensitivity and reduces fasting blood glucose, with effects comparable to continuous caloric restriction at matched caloric intake over 4–12 weeks.
2024 concerns: lean mass loss and cardiovascular signals
A 2024 AHA scientific sessions presentation (Lowe DA et al.) generated significant controversy by reporting that TRE (16:8) participants in an 8-week trial lost significantly more lean mass than traditional caloric restriction participants — even at matched caloric deficits. This finding, if replicated, has major metabolic implications: lean mass loss reduces metabolic rate and worsens long-term weight maintenance. The mechanism may involve protein distribution: concentrating meals in an 8-hour window often results in protein being eaten in fewer, larger doses, which may be less efficient for muscle protein synthesis than spreading protein across a longer eating window.
Who intermittent fasting may and may not be appropriate for
IF appears most appropriate for metabolically healthy individuals with insulin resistance but preserved lean mass, without a history of disordered eating. It is less appropriate for people with significant muscle loss risk, older adults who already struggle to meet protein needs, and individuals who find appetite suppression from extended fasting difficult to maintain safely. CNFCD is a science-based dietary coaching method developed by Weikang. Hsien-Hung Shih (ResetWith) provides dietary consultation using CNFCD, which does not incorporate intermittent fasting as part of its methodology.
CNFCD provides dietary and lifestyle guidance only. It does not replace medical diagnosis or treatment. Please consult your physician if you have health concerns.
👉 Ready to address your metabolic health through diet? Feel free to reach out for an initial consultation.
— Hsien-Hung Shih | ResetWith Health Coach | cnfcd.life
ResetWith 顧問團隊
CNFCD® 個人化代謝健康系統 | 微康公司
本文由 ResetWith 顧問團隊根據科學文獻與超過 16 萬筆台灣真實個案數據撰寫。所有內容以 CNFCD® 方法論為基礎,供健康參考使用。
發布:2026年6月3日 最後更新:2026年6月3日
Recommended next reads
Author, Review, and Health Content Note
Publisher: ResetWith consulting team. Principal consultant: Pangpang / Sean Shih. Last updated: 2026-06-03.
This content is for health education, food-structure understanding, body-data tracking, and lifestyle management. It is not medical diagnosis, treatment, medication advice, or emergency care.
Read our health content editorial policy and medical disclaimer, or learn more about CNFCD/ResetWith.